Cisplatin and TNF-α downregulate transcription of Bcl-xL in murine malignant mesothelioma cells

Biochemical and Biophysical Research Communications

Volumn 337, Issue 3, 2005, Pages 983-991

  Fox, Simon A ^a   Kusmiaty, ^a   Loh, Suzanne S W ^a   Dharmarajan, Arun M ^b   Garlepp, Michael J ^a  

^a CURTIN UNIVERSITY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Apoptosis; Bcl xL; Caspase; Cisplatin; Mesothelioma; TNF

Indexed keywords

CASPASE 3; CISPLATIN; DNA FRAGMENT; MYC PROTEIN; ONCOTAIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; DRUG SENSITIVITY; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; MESOTHELIOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-X PROTEIN; CELL LINE, TUMOR; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; MESOTHELIOMA; MICE; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MURINAE;

EID: 26844477897     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.09.147     Document Type: Article

References (35)

1. T. Berghmans, M. Paesmans, Y. Lalami, I. Louviaux, S. Luce, C. Mascaux, A.P. Meert, and J.P. Sculier Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis Lung Cancer 38 2002 111 121
2. M.R Davis, L.S. Manning, D. Whitaker, M.J. Garlepp, and B.W. Robinson Establishment of a murine model of mesothelioma Int. J. Cancer 52 1992 881 886
3. B.W.S. Robinson, J.A. Davidson, and M.J. Garlepp The immunology and immunopathology of malignant mesothelioma R.L. Kradin B.W.S. Robinson Immunopathology of Lung Disease 1996 Butterworth-Heinemann Boston 491 513
4. L.S. Manning, D. Whitaker, A.R. Murch, M.J. Garlepp, M.R. Davis, A.W. Musk, and B.W. Robinson Establishment and characterisation of five human malignant mesothelioma cell lines derived from pleural effusions Int. J. Cancer 47 1991 285 290
5. M. Odaka, D.H. Sterman, R. Wiewrodt, Y. Zhang, M. Kiefer, K.M. Amin, G.P. Gao, J.M. Wilson, J. Barsoum, L.R. Kaiser, and S.M. Albelda Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity Cancer Res. 61 2001 6201 6212
6. P.L. Friedlander, C.L. Delaune, J.M. Abadie, M. Toups, J. LaCour, L. Marrero, Q. Zhong, and J.K. Kolls Efficacy of CD40 ligand gene therapy in malignant mesothelioma Am. J. Respir. Cell Mol. Biol. 29 2003 321 330
7. J.P. Hegmans, A. Hemmes, J.G. Aerts, H.C. Hoogsteden, and B.N. Lambrecht Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells Am. J. Respir. Crit. Care Med. 171 2005 1168 1177
8. P. Jordan, and M. Carmo-Fonseca Molecular mechanisms involved in cisplatin cytotoxicity Cell Mol. Life Sci. 57 2000 1229 1235
9. Y. Soini, V. Kinnula, R. Kaarteenaho-Wiik, E. Kurttila, K. Linnainmaa, and P. Paakko Apoptosis and expression of apoptosis regulating proteins bcl-2, mcl-1, bcl-x, and bax in malignant mesothelioma Clin. Cancer Res. 5 1999 3508 3515
10. P.M. Cury, D.N. Butcher, B. Corin, and A.G. Nicholson The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis J. Pathol. 189 1999 251 257
11. W.R. Smythe, I. Mohuiddin, M. Ozveran, and X.X. Cao Antisense therapy for malignant mesothelioma with oligonucleotides targeting the bcl-xl gene product J. Thorac. Cardiovasc. Surg. 123 2002 1191 1198
12. X.X. Cao, I. Mohuiddin, F. Ece, D.J. McConkey, and W.R. Smythe Histone deacetylase inhibitor downregulation of bcl-xl gene expression leads to apoptotic cell death in mesothelioma Am. J. Respir. Cell Mol. Biol. 25 2001 562 568
13. S. Hopkins-Donaldson, R. Cathomas, A.P. Simoes-Wust, S. Kurtz, L. Belyanskaya, R.A. Stahel, and U. Zangemeister-Wittke Induction of apoptosis and chemosensitization of mesothelioma cells by Bcl-2 and Bcl-xL antisense treatment Int. J. Cancer 106 2003 160 166
14. M. Ramael, J. Van den Bossche, C. Buysse, I. Deblier, K. Segers, and E. Van Marck Immunoreactivity for c-fos and c-Myc protein with the monoclonal antibodies 14E10 and 6E10 in malignant mesothelioma and non-neoplastic mesothelium of the pleura Histol. Histopathol. 10 1995 639 643
15. H. Sandhu, W. Dehnen, M. Roller, J. Abel, and K. Unfried mRNA expression patterns in different stages of asbestos-induced carcinogenesis in rats Carcinogenesis 21 2000 1023 1029
16. M.R Sprick, and H. Walczak The interplay between the Bcl-2 family and death receptor-mediated apoptosis Biochem. Biophys. Acta 1644 2004 125 132
17. S.A. Fox, S. Loh, A.L. Thean, and M.J. Garlepp Identification of differentially expressed genes in murine mesothelioma cell lines of differing tumorigenicity using suppression subtractive hybridisation Biochim. Biophys. Acta 1688 2004 237 244
18. J. Sambrook, E.F. Fritsch, and T. Maniatis Molecular Cloning: A Laboratory Manual 1989 Cold Spring Harbor Laboratory Press Cold Spring Harbor, New York
19. S. Rozen, and H.J. Skaletsky Primer3 on the WWW for general users and for biologist programmers S. Krawetz S. Misener Bioinformatics Methods and Protocols: Methods in Molecular Biology 2000 Humana Press Totowa, NJ 365 386
20. F. Pattyn, F. Spleeman, A. De Paepe, and J. Vandesompele RTPrimerDB: the real-time PCR primer and probe database Nucleic Acids Res. 31 2003 122 123
21. J. Vandesompele, K. De Preter, F. Pattyn, B. Poppe, N. Van Roy, A. De Paepe, and F. Speleman Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biol. 3 2002 1 12
22. W. Liu, E. Bodle, J. Chen, M. Gao, G.D. Rosen, and V.C. Broaddus Tumour necrosis factor-related apoptosis-inducing ligand and chemotherapy cooperate to induce apoptosis in mesothelioma cell lines Am. J. Respir. Cell Mol. Biol. 25 2001 111 118
23. M. Raisova, A.M. Hossini, J. Eberle, C. Riebeling, T. Wieder, I. Sturm, P.T. Daniel, C.E. Orfanos, and C.C. Geilen The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis J. Invest. Dermatol. 117 2001 333 340
24. L. Zhang, J. Yu, B.H. Park, K.W. Kinzler, and B. Vogelstein Role of BAX in the apoptotic response to anticancer agents Science 290 2000 989 992
25. L. Sevilla, A. Zaldumbide, P. Pognonec, and K.E. Boulukos Transcriptional regulation of the bcl-x gene encoding the anti-apoptotic Bcl-xL protein by Ets, Rel/NFkappaB, STAT and AP1 transcription factor families Histol. Histopathol. 16 2001 595 601
26. D. Li, E. Ueta, T. Kimura, T. Yamamoto, and T. Osaki Reactive oxygen species (ROS) control the expression of Bcl-2 family proteins by regulating their phosphorylation and ubiquitination Cancer Sci. 95 2004 644 650
27. U. Gaur, and B.B. Aggarwal Regulation of proliferation, survival and apoptosis by members of the TNF superfamily Biochem. Phramacol. 66 2003 1403 1408
28. K. Schmelz, T. Wieder, I. Tamm, A. Muller, F. Essmann, C.C. Geilen, K. Schulze-Osthoff, B. Dorken, and P.T. Daniel Tumor necrosis factor alpha sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-kappaB Oncogene 23 2004 6743 6759
29. N. Singh, N. Khanna, H. Sharma, S. Kundu, and S. Azmi Insights into the molecular mechanism of apoptosis induced by TNF-alpha in mouse epidermal JB6-derived RT-101 cells Biochem. Biophys. Res. Commun. 295 2002 24 30
30. P. Valente, D. Arzani, A. Cesario, S. Margaritora, E. Carbone, and P. Russo TNF increases camptothecin-induced apoptosis by inhibition of NF-kappaB Eur. J. Cancer 39 2003 1468 1477
31. P. Russo, A. Catassi, D. Malacarne, S. Margaritora, A. Cesario, L. Festi, A. Mule, L. Ferri, and P. Granone Tumor necrosis factor enhances SN38-mediated apoptosis in mesothelioma cells Cancer 103 2005 1503 1518
32. M.C. Abraham, and S. Shaham Death without caspases, caspases without death Trends Cell Biol. 14 2004 184 193
33. F. Doonan, M. Donovan, and T.G. Cotter Caspase-independent photoreceptor apoptosis in mouse models of retinal degeneration J. Neurosci. 23 2003 5723 5731
34. H.K. Lorenzo, and S.A. Susin Mitochondrial effectors in caspase-independent cell death FEBS Lett. 557 2004 14 20
35. K.M. Henkels, and J.J. Turchi Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines Cancer Res. 59 1999 3077 3083